A drop in pending homes sales weighed the markets down to a lower open with the Dow falling 64 points to 17,715. Nasdaq lost 19 points to 5,075.
On the upside
LifeLock (NYSE: LOCK) reported a smaller than expected loss for the third quarter and settled litigation with the Federal Trade Commission.
Exact Sciences (Nasdaq: EXAS) reported a loss for the third quarter but revenue from its Cologuard test has surged.
Revance Therapeutics (Nasdaq: RVNC) reported positive 6-month results from a Phase 2 study of injectable RT002.
On the downside
GNC Holdings (NYSE: GNC) disappointed with lower third quarter earnings that missed estimates and cut its full year outlook.
Third quarter earnings and revenue for GoPro (Nasdaq: GPRO) fell short of expectations prompting downgrades.
NXP Semiconductors (Nasdaq: NXPI) reported higher third quarter earnings and revenue but the company warned of weakening demand due to uncertain economic conditions.
In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 3 on the NYSE and by nearly 5 to 4 on Nasdaq. The broader S&P 500 lost 5 points to 2,085. Bitcoin climbed $10 to $310.
